(Q43122651)

14 November 2017

title

Controlling lipids in a high-risk population with documented coronary artery disease for secondary prevention: are we doing enough? (English)

1 reference

14 November 2017

main subject

coronary artery disease

1 reference

Mukesh Singh

1

1 reference

14 November 2017

Shui Hao Chin

2

1 reference

14 November 2017

Paul D Giles

3

1 reference

14 November 2017

David Crothers

4

1 reference

14 November 2017

Karim Al-Allaf

5

1 reference

14 November 2017

Jawad M Khan

6

1 reference

14 November 2017

publication date

1 October 2010

1 reference

European Journal of Cardiovascular Prevention and Rehabilitation

14 November 2017

published in

1 reference

14 November 2017

volume

17

1 reference

14 November 2017

issue

5

1 reference

14 November 2017

page(s)

556-561

1 reference

JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice

14 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338978E

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338978E

European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338978E

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338978E

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338978E

Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338978E

Rationale and design of the Department of Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial (HIT) for secondary prevention of coronary artery disease in men with low high-density lipoprotein cholesterol and desirable low-densi

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338978E

How much does HDL cholesterol add to risk estimation? A report from the SCORE Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338978E

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338978E

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338978E

Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338978E

Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338978E

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338978E

Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338978E

Prospective studies on the relationship between high-density lipoprotein cholesterol and cardiovascular risk: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338978E

Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338978E

Opportunity for intervention to achieve American Heart Association guidelines for optimal lipid levels in high-risk women in a managed care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338978E

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338978E

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338978E

Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study)

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338978E

High-density lipoprotein cholesterol in the cardiovascular equation: does the "good" still count?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338978E

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338978E

Simvastatin with or without ezetimibe in familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338978E

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338978E

Determinants of Arterial Wall Remodeling During Lipid-Lowering Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328338978E

10.1097/HJR.0B013E328338978E

21 January 2018

Identifiers

DOI

1 reference

14 November 2017

1 reference